Lianbio

Lianbio company information, Employees & Contact Information

Explore related pages

Lianbio email format Lianbio management contacts

Related company profiles:

LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and other major Asian markets through partnerships that provide access to innovative therapeutic discoveries.

Company Details

Employees
52
Founded
-
Address
9th Floor, Kerry Parkside, 1155 Fangdian Road,
Email
IR****@****Bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
lianbio.com
Keywords
Princeton.
HQ
Shanghai, PRC
Competitors
Panacea Venture, ANI Pharmaceuticals, Inc., ProfoundBio, Hasten Biopharmaceutical Co., Ltd., BeiGene, Biorich International, Kardigan, Bristol Myers Squibb, Galderma, Full-Life Technologies.
Looking for a particular Lianbio employee's phone or email?

Lianbio Questions

News

LianBio to shut down, return cash to investors - BioPharma Dive

LianBio to shut down, return cash to investors BioPharma Dive

LianBio Announces Completion of Strategic Review - GlobeNewswire

LianBio Announces Completion of Strategic Review GlobeNewswire

LianBio CEO Yizhe Wang Resigns - citybiz

LianBio CEO Yizhe Wang Resigns citybiz

LianBio Announces Voluntarily Delisting from Nasdaq - Yahoo Finance

LianBio Announces Voluntarily Delisting from Nasdaq Yahoo Finance

LianBio lays off half of workforce as biotech begins to wind down - Fierce Biotech

LianBio lays off half of workforce as biotech begins to wind down Fierce Biotech

LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets - Stock Titan

LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets Stock Titan

Perceptive Advisors Launches LianBio with Multiple Strategic Alliances and Establishes Operating Platform - Business Wire

Perceptive Advisors Launches LianBio with Multiple Strategic Alliances and Establishes Operating Platform Business Wire

LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets - GlobeNewswire

LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets GlobeNewswire

With $350M payment to LianBio, Bristol Myers scoops up Asian rights to Camzyos - Fierce Pharma

With $350M payment to LianBio, Bristol Myers scoops up Asian rights to Camzyos Fierce Pharma

LianBio Chief Financial Officer Yi Larson to Retire - citybiz

LianBio Chief Financial Officer Yi Larson to Retire citybiz

NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets - Business Wire

NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets Business Wire

LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis - Yahoo Finance

LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis Yahoo Finance

LianBio snags $325M IPO, slightly bigger than the multi-partnered biotech's 2020 series A - Fierce Biotech

LianBio snags $325M IPO, slightly bigger than the multi-partnered biotech's 2020 series A Fierce Biotech

LianBio President Debra Yu Resigns - citybiz

LianBio President Debra Yu Resigns citybiz

Pfizer Opts In to LianBio Rights to Respiratory Syncytial - GlobeNewswire

Pfizer Opts In to LianBio Rights to Respiratory Syncytial GlobeNewswire

LianBio Appoints Yi Larson as Chief Financial Officer - citybiz

LianBio Appoints Yi Larson as Chief Financial Officer citybiz

LianBio Announces Pricing of Initial Public Offering - GlobeNewswire

LianBio Announces Pricing of Initial Public Offering GlobeNewswire

Landos Biopharma and LianBio Announce Exclusive - GlobeNewswire

Landos Biopharma and LianBio Announce Exclusive GlobeNewswire

Tang Capital’s Concentra back with another buyout offer, this time for LianBio - Fierce Biotech

Tang Capital’s Concentra back with another buyout offer, this time for LianBio Fierce Biotech

LianBio to extend cutting-edge therapeutics in China and major Asian market - BioSpectrum Asia

LianBio to extend cutting-edge therapeutics in China and major Asian market BioSpectrum Asia

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China - Malay Mail

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China Malay Mail

Companies like Lianbio

Galderma logo - Similar company to Lianbio

Galderma

8.13K
Panacea Venture logo - Similar company to Lianbio

Panacea Venture

25
ProfoundBio logo - Similar company to Lianbio

Profoundbio

11
Full-Life Technologies logo - Similar company to Lianbio

Full-Life Technologies

64
Biorich International logo - Similar company to Lianbio

Biorich International

NA
BeiGene logo - Similar company to Lianbio

Beigene

2.93K
Kardigan logo - Similar company to Lianbio

Kardigan

108
Hasten Biopharmaceutical Co., Ltd. logo - Similar company to Lianbio

Hasten Biopharmaceut...

45
Bristol Myers Squibb logo - Similar company to Lianbio

Bristol Myers Squibb

38.47K
ANI Pharmaceuticals, Inc. logo - Similar company to Lianbio

Ani Pharmaceuticals,...

601

Top Lianbio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant